ArticleThe Eurasian journal of medicine2026
Distribution of HFE Gene Variants in Patients Undergoing Genetic Testing in Türkiye: A Retrospective Analysis of 643 Cases.
Article in The Eurasian journal of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHereditary hemochromatosis (HH) is a common genetic disorder of iron metabolism, most frequently associated with pathogenic variants in the HFE gene. The distribution of HFE variants shows marked population-specific differences. This study aimed to evaluate the frequency and genotype distribution of major HFE variants in a large Turkish cohort.
methodsA total of 643 patients who underwent HFE gene sequencing at a single tertiary center were retrospectively analyzed. Genotype and allele frequencies of common HFE variants, including p.Cys282Tyr, p.His63Asp, and p.Ser65Cys, as well as rare variants were calculated. Clinical and biochemical parameters were not included, and the analysis focused exclusively on genetic frequency data.
resultsAmong the 643 patients, 424 (65.9%) were wild-type for HFE. The most frequent variant was H63D heterozygosity, detected in 166 patients (25.8%). p.Cys282Tyr homozygosity was identified in only 4 patients (0.6%). Compound heterozygosity for p.Cys282Tyr and p.His63Asp was observed in 1 patient, while another patient showed homozygous His63Asp with heterozygous p.Arg224Trp. In terms of allele frequencies, p.His63Asp was the most common with 0.183, followed by p.Cys282Tyr with a frequency of 0.012.
conclusionThe findings demonstrate a distinct HFE genetic profile in the Turkish population, characterized by a low frequency of p.Cys282Tyr and a high prevalence of p.His63Asp heterozygosity. These results highlight the importance of population-specific genetic data for accurate interpretation of HFE testing and HH risk assessment. Cite this article as: Kablan A, Sezer A, Bakır A, et al. Distribution of HFE gene variants in patients undergoing genetic testing in Türkiye: A retrospective analysis of 643 cases. Eurasian J Med. 2026, 58(3), 1390, doi: 10.5152/eurasianjmed.2026.261390.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.